Introduction {#S1}
============

The blood oxygenation level-dependent (BOLD) contrast in functional MRI (fMRI) studies has been extensively used to study group differences and to relate brain response to overt behavior. The BOLD signal is a function of changes in cerebral blood flow (CBF), volume, and oxygenation. A key challenge, however, in investigating BOLD fMRI task-associated responses in aging and disease is that there may be considerable variability in the responses across subjects depending on the intrinsic vascular reactivity to neural activity ([@B1]--[@B3]). The mechanisms underlying BOLD blood flow changes are influenced by vascular and neural factors that are poorly understood ([@B4]). The strong dependence between CBF and the electrical activity of the brain is accomplished by a process known as neurovascular coupling, whereby increases in neuronal activity is tightly related to corresponding increases in regional CBF ([@B5]--[@B8]). There is growing evidence that neurovascular coupling is affected in healthy aging and in neurological disorders such as stroke, complicating straightforward interpretation of the BOLD signal.

Several studies have used a breath-hold task in the MR scanner to measure the brain's cerebrovascular response to a stimulus and a hypercapnic hemodynamic calibration method to eliminate inter-subject variability in task fMRI studies \[e.g., Ref. ([@B9]--[@B11])\]. However, using a breath-hold task with stroke patients poses additional demands on the subjects, potentially leading to compliance issues, and results could be further confounded by inter-subject differences in the extent of performing the breath-hold task. One alternative proposed for the calibration of task fMRI is the resting-state fluctuation amplitude \[RSFA; ([@B12])\]. Several studies have reported that the amplitude of fluctuations in resting-state fMRI in large part reflects the naturally occurring variations in cardiac rhythm and in respiratory rate and depth and approximates the BOLD response to a hypercapnic challenge ([@B12]--[@B15]). Calibration using RSFA provides a practically convenient method for removing intra- and inter-subject variability arising from vascular factors. Kannurpatti and colleagues have previously used this method in young and older healthy normals ([@B16]). Kannurpatti et al. reported that both intra- and inter-subject variability differences were reduced after calibration with RSFA. Additionally, the amplitude and spatial extent of group activation were lower in the older than in the younger group prior to and after calibration. In the current study, we investigated the efficacy of this technique in stroke. We applied the RSFA calibration to a high-level cognitive fMRI task in early stage stroke patients and in age-matched older healthy control subjects. In order to focus on a relatively homogenous stroke sample, we tested this approach in a sample of early stage left hemisphere stroke patients (mean time since stroke onset less than 7 days). The cognitive task used in this study was a verbal (or phonemic or letter) fluency task in which subjects were required to silently generate words starting with specific letters. This task is known to elicit reliable activation in both older controls and stroke patients and has been extensively used with patient populations ([@B17]--[@B19]). Along with investigating within- and between-group differences in task-associated BOLD signal amplitude and activation volumes, we also investigated the efficacy of this approach in select regions-of-interest (ROIs) typically activated during performance of this task.

Materials and Methods {#S2}
=====================

Participants {#S2-1}
------------

The current study is part of an ongoing research study investigating brain reorganization changes following stroke. Data from 15 early left hemisphere stroke patients (mean age = 64 years, range 44--84 years, 11 males, 12 right handed) and 21 healthy controls (mean age = 62.7 years, range 55--77 years, 11 males, 20 right handed) were analyzed for this study. *Inclusion criteria* for the stroke group were patients 18 years or older with ischemic stroke and without a history of major psychiatric illness, confounding neurological disorders, or alcohol or substance abuse. Healthy control group included subjects aged 18 years or older without a history of major psychiatric illness, confounding neurological disorders, vascular risk factors, or alcohol or substance abuse.

The demographic characteristics of all participants are shown in Table [1](#T1){ref-type="table"}. Table [2](#T2){ref-type="table"} lists clinical characteristics of the stroke patients in the study. All subjects provided written informed consent and were paid compensation of \$75. This study was conducted in accordance with a human subjects' protocol approved by the University's Health Sciences Institutional Review Board.

###### 

Demographic characteristics of healthy controls in the study.

  Healthy control   Age   M/F   Handedness   Education (years)   Acute stroke   Age   M/F   Handedness   Education (years)
  ----------------- ----- ----- ------------ ------------------- -------------- ----- ----- ------------ -------------------
  1                 71    F     R            18                  1              67    M     L            21
  2                 67    M     R            21                  2              58    M     R            16
  3                 74    F     R            16                  3              79    M     R            21
  4                 61    F     R            12                  4              58    F     R            12
  5                 55    M     R            21                  5              70    M     R            20
  6                 58    M     L            18                  6              63    M     L            12
  7                 60    F     R            16                  7              55    M     R            12
  8                 60    M     R            17                  8              62    M     R            16
  9                 55    F     R            16                  9              75    M     R            18
  10                59    F     R            21                  10             84    M     L            16
  11                63    F     R            18                  11             44    F     R            16
  12                62    F     R            18                  12             59    F     R            18
  13                56    M     R            22                  13             62    F     R            16
  14                61    M     R            14                  14             62    M     R            14
  15                62    F     R            18                  15             61    M     R            14
  16                77    M     R            14                                                          
  17                62    M     R            16                                                          
  18                62    F     R            18                                                          
  19                63    M     R            16                                                          
  20                61    M     R            16                                                          
  21                68    M     R            18                                                          

*M, male; F, female; R, right; L, left*.

###### 

Clinical characteristics of early stroke patients.

  Patient   Age   Time since stroke (days)   NIH stroke score   Lesion location
  --------- ----- -------------------------- ------------------ ---------------------------------------------------
  1         67    5                          0                  Left lateral medulla
  2         58    5                          0                  Left corticospinal tract
  3         79    6                          2                  Left MCA
  4         58    7                          1                  Left frontal
  5         70    2                          2                  Left parietal
  6         63    2                          2                  Left putamen
  7         55    3                          0                  Left MCA
  8         62    9                          0                  Left parietal
  9         75    6                          1                  Left occipital
  10        84    5                          1                  Left MCA
  11        44    5                          7                  Left insula, L frontal
  12        59    2                          2                  Left posterior insula, left angular gyrus
  13        62    5                          2                  Left MCA
  14        62    12                         0                  Left paramedian midbrain
  15        61    5                          0                  Left peri thalamic region and left corona radiate

*MCA, middle cerebral artery*.

Data Acquisition {#S2-2}
----------------

### Behavioral Measures {#S2-2-1}

Verbal fluency outside the scanner was assessed by forms of the Controlled Oral Word Association Test ([@B20]), which requires subjects to produce words beginning with a letter of the alphabet, "F," "A," and "S" in three respective 1-min trials. There is evidence that individuals with vascular risk factors for stroke and stroke patients show impaired performance on the verbal fluency task when compared to age- and education-matched healthy normals ([@B21]--[@B23]). Each subject was asked to generate as many words as possible to each of the letters "F," "A," and "S" per minute. Instructions were given orally and responses recorded on paper by the examiner. Subjects were asked to avoid repetitions, proper nouns, and add-ons (e.g., "please," "pleasing," "pleasingly," etc.). Responses to each letter were recorded, and verbal fluency raw scores were based on the total number of correct responses produced by the participants across the three letter conditions. Normed verbal fluency scores were calculated by subtracting the age and education appropriate control mean score from the individual raw score and dividing by the corresponding SD.

#### MRI Data Acquisition {#S2-2-1-1}

A 3-T GE whole-body MRI scanner (GE Healthcare, Waukesha, WI, USA) equipped with a 8-channel head coil was used to acquire the MRI images. An axial localizer scan was obtained to verify subject positioning and plan slice acquisition. T1-weighted axial anatomical images were acquired at the beginning of each session using FSPGR BRAVO sequence (TR = 8.132 ms, TE = 3.18 ms, TI = 450 ms, 256 × 256 matrix, 156 slices, flip angle = 12°, FOV = 25.6 cm, slice thickness = 1 mm). Ten minutes, eyes closed, resting-state scans were obtained using single-shot echo-planar T2\*-weighted imaging with the following acquisition parameters: TR = 2.6 s, 231 time-points, TE = 22 ms, FOV = 22.4 cm, flip angle = 60°, voxel dimensions 3.5 mm × 3.5 mm, 3.5 mm slice thickness, 40 slices. Functional data were acquired *via* echo-planar T2\*-weighted imaging either with the same parameters as the resting or with parameters: TR = 2.0 s, 90 time-points, TE = 22 ms, FOV = 22.4 cm, flip angle = 60°, voxel dimensions 3.75 mm × 3.75 mm, 4.0 mm slice thickness, 40 slices. Each task fMRI scan followed a block design consisting of four 20-s blocks alternating with five 20-s blocks of rest, for a total scan length of 3 min. During the task blocks, subjects viewed the letters "F," "A," "S," and "T" on the screen through the overhead mirror, and during the rest block subjects viewed the letter "REST," and were instructed to rest and not think of anything in particular. Subjects wore earplugs to attenuate scanner noise, and foam padding was placed around the subject's head to minimize movement.

Data Preprocessing {#S2-3}
------------------

### fMRI Data {#S2-3-1}

All preprocessing of task and resting fMRI data was performed using the AFNI package ([@B24]).

1.  *Uncalibrated percent signal change in task* (standard preprocessing of the task fMRI data): for the verbal fluency task, data were first aligned to the anatomical and normalized to standard Montreal Neurological Institute (MNI) space. The first four volumes were discarded to allow for steady-state imaging. Images were then resampled to 3.0 mm isotropic, despiked, volume registered, and spatially smoothed using a 4 mm full-width at half-maximum Gaussian kernel. The time series within each voxel was scaled to percent signal and standard activation maps were computed using a general linear model (GLM) with a canonical gamma variate hemodynamic response function convolved with a boxcar reference waveform and six rigid-body motion parameters and their derivatives regressed. Motion censoring (per TR motion \> 0.3 mm) was included in the GLM. The magnitude of task related activation was derived from the beta-weights, which represent the BOLD percent signal change during the task (uncalibrated BOLD amplitude or standard percent signal change). Standard activation maps were also derived using AFNI's 3dClustSim \[*p* \< 0.05 (33 voxels)\].

2.  *Calibrated percent signal change in task*: same preprocessing steps as in (1) were adopted, except that the data were not scaled to percent signal change prior to the GLM. Temporal SD was computed and then divided by the hemodynamic scaling factor (RSFA) which was computed as described below in (4) to get the calibrated BOLD percent signal change ([@B16]).

3.  *Uncalibrated task activation volume*: same preprocessing steps as in (1). Activation volume was defined as the number of voxels whose percent signal change exceeds the 99th percentile of the uncalibrated null distribution. The computation of this null distribution is described below. To obtain a model free statistical estimate using a data driven approach as implemented by Kannurpatti and colleagues ([@B16]), we computed the 99th percentile level of the null distribution, i.e., the distribution obtained from the resting-state scan on a subject-wise basis. To obtain this null distribution, the resting-state data were preprocessed using standard preprocessing steps and scaled to percent signal change and the null distribution computed using a GLM, in which six motion parameters and their derivatives, motion censoring (per TR motion \> 0.3 mm) and a stimulus regressor corresponding to the task design extended to match the length of the resting scan, were included ([@B16]). To be consistent with the preprocessing of the task data, no additional regressors such as cerebrospinal fluid or white matter signals were included and no band pass filtering was applied. The uncalibrated task-related activation volume was defined as the number of voxels that exceed the 99th percentile of this whole brain uncalibrated null distribution.

4.  *Calibrated task activation volume*: to obtain the null distribution after calibration, the temporal SD during task was divided by the RSFA. Following Kannurpatti and Biswal ([@B12]) and Kannurpatti et al. ([@B16]), RSFA is defined as the temporal SD obtained from resting-state data (i.e., RSFA = ΔBOLD~rest~ = SD~rest~). To compute the threshold for significance, SD of the first half of the resting-state time series (RSFA1) was divided by the SD of the second half (RSFA2) to obtain the ratio in every voxel (this procedure avoided the acquisition of another resting-state scan). The *calibrated task-related activation* volume was defined as the number of voxels that exceed the 99th percentile of this whole brain calibrated null distribution (RSFA1 ÷ RSFA2). The 99th percentile value was also applied to derive activation maps for comparison with pre-calibration maps using the same cluster correction approach.

All preprocessing was done in subject space and then images normalized to MNI space for computing uncalibrated and calibrated BOLD signal amplitude and activation volumes.

### Selection of ROIs {#S2-3-2}

In order to evaluate the RSFA calibration method at the ROI level, an almost identical process as outlined above was used for computing the BOLD percent signal change and activation volumes with the key difference that the 99th percentile threshold value was computed for each ROI to compute BOLD signal amplitude and activation volumes at an uncorrected significance threshold of *p* \< 0.01. Based on a recent meta-analysis of the verbal fluency task, the four selected ROIs included: two regions in the left inferior frontal gyrus (MNI coordinates, −48, 28, 14 and −52, 12, 0), and two regions in the right inferior frontal gyrus (50, 20, 2 and 52, 18, 6) ([@B19]).

Statistical Tests {#S2-4}
-----------------

Chi-squared tests were run to examine group differences on demographic variables of gender and handedness. Independent *t*-tests were applied to compute between-group differences in age, education, and on the raw and normed verbal fluency scores obtained outside the scanner. Bartlett's test was used to test for homogeneity of variances across the groups. Differences between group means on the imaging variables of whole brain BOLD amplitude and task activation volumes were tested using the unpaired Student's *t*-test and changes within each group, from pre- to post-calibration, were tested using paired *t*-test (a *p* \< 0.05 was considered statistically significant). For ROI-wise comparisons, a value of *p* \< 0.01 (=0.05/4 ROIs; Bonferroni correction) was considered statistically significant.

Results {#S3}
=======

Chi-squared tests showed no significant differences between the groups on gender (*p* = 0.16) or handedness (*p* = 0.16). There were also no significant differences in age (*p* = 0.65) or education (*p* = 0.20) between stroke patients and healthy controls.

Behavioral {#S3-1}
----------

### Letter Fluency Task {#S3-1-1}

There were significant differences between stroke patients and healthy controls on the letter fluency task raw scores (mean = 27 in acute strokes vs. 51 in healthy controls, *p* \< 0.00000) and normed scores (*p* \< 0.00000) (Figure [1](#F1){ref-type="fig"}).

![Axial view of the group activation maps before calibration during the verbal fluency task in controls (top), patients (middle), and difference map (controls \> patients, bottom panel). Maps are in radiological convention, left = right, *p* \< 0.05, corrected using AFNI's 3dClustSim. Warm colors indicate areas of activation with respect to the rest block; cool colors indicate deactivation with respect to the rest block.](fneur-08-00283-g001){#F1}

Imaging Data {#S3-2}
------------

Bartlett's test showed no differences in variance in whole brain activation volume between groups (*p* \> 0.11).

### Pre-Calibration Activation Maps, BOLD Amplitude, and Activation Volumes {#S3-2-1}

Prior to calibration with RSFA, whole brain group activation volumes were significantly smaller in the patient group, compared to the controls during the verbal fluency task (*p* \< 0.05). Whole brain activation maps show regions of activation typically found on this task (Figure [2](#F2){ref-type="fig"}, top). Table [3](#T3){ref-type="table"} lists the top five regions of activation and corresponding MNI coordinates for each group and for the between-group comparison on the verbal fluency task. Controls showed significantly greater activation in the left inferior frontal gyrus, the right inferior temporal gyrus, right cerebellum, and the left inferior occipital gyrus.

![Axial view of the group activation maps after calibration with RSFA during the verbal fluency task in controls (top), patients (bottom panel). Maps are in radiological convention, left = right, *p* \< 0.05, corrected. There were no significant group differences after calibration.](fneur-08-00283-g002){#F2}

###### 

Regions of activation (uncalibrated) in controls and patients on the verbal fluency task.

                             Montreal Neurological Institute coordinates                                                                    
  -------------------------- --------------------------------------------- ----- ----- -------------------------------------------- ------- -------
  1                          +6                                            −18   +48   L supplementary motor area (SMA)             1,779   7.48
  2                          −33                                           60    −30   R cerebellum                                 994     7.91
  3                          −30                                           −21   12    R insula                                     464     7.28
  4                          −63                                           48    18    R superior temporal gyrus                    383     −6.34
  5                          33                                            42    42    L inferior parietal lobule                   356     6.68
  **Patients**                                                                                                                              
  1                          −60                                           +54   +24   R angular gyrus                              149     −6.33
  2                          −27                                           +57   −21   R cerebellum                                 114     7.91
  3                          +45                                           +9    +54   L postcentral gyrus                          87      5.84
  4                          +45                                           −33   +24   L inferior frontal gyrus (p. triangularis)   50      6.36
  5                          +3                                            −3    +66   L SMA                                        43      6.95
  **Controls \> patients**                                                                                                                  
  1                          39                                            −9    +24   L inferior frontal gyrus (p. opercularis)    144     7.45
  2                          −51                                           +54   −12   R inferior temporal gyrus                    96      6.44
  3                          −24                                           +72   −54   R cerebellum                                 82      7.69
  4                          +39                                           +66   −3    L inferior occipital gyrus                   63      4.51
  5                          −24                                           +69   −27   R cerebellum                                 46      7.91

### Post-Calibration Activation Maps, BOLD Amplitude, and Activation Volumes {#S3-2-2}

After calibration with RSFA, whole brain group activation volumes remained smaller in the patient group, compared to the controls during the verbal fluency task, but this difference was not statistically significant (*p* = 0.22). Table [4](#T4){ref-type="table"} lists the top five regions of activation and corresponding MNI coordinates for each group on the verbal fluency task. Figure [3](#F3){ref-type="fig"} shows within- and between-group differences in whole brain activation volume before and after calibration.

###### 

Regions of activation (calibrated) in controls and patients on the verbal fluency task.

  After calibration   Montreal Neurological Institute coordinates                                                  
  ------------------- --------------------------------------------- ----- ----- ---------------------------- ----- ------
  1                   30                                            −24   3     L insula                     853   5.16
  2                   −60                                           45    27    R supramarginal gyrus        513   5.16
  3                   45                                            66    −12   L inferior occipital gyrus   147   4.26
  4                   −39                                           −54   −3    R middle frontal gyrus       123   4.26
  5                   −24                                           9     −24   R parahippocampal gyrus      104   4.26
  **Patients**                                                                                                     
  1                   33                                            −9    −9    L insula                     75    5.83
  2                   45                                            0     9     L rolandic operculum         67    4.12
  3                   42                                            63    −15   L fusiform gyrus             47    4.12
  4                   −30                                           −18   −12   R insula                     44    4.61
  5                   6                                             45    −63   L cerebellum                 43    4.12

![Within- and between-group differences in whole brain activation volumes.](fneur-08-00283-g003){#F3}

ROI Comparisons {#S3-3}
---------------

Activation volumes reduced in both groups after calibration. Between-group differences were significant prior to calibration in two of four regions but these differences were not significant after calibration. Within-group differences from pre- to post-calibration were significant for three of four regions in controls, and for one region, the left IFG1, in patients (Table [5](#T5){ref-type="table"} and Figure [4](#F4){ref-type="fig"}).

###### 

Region-of-interest-wise group activation volumes (number of voxels) and *p*-values associated with within- and between-group differences.

                             Left inferior frontal 1   Left inferior frontal 2   Right inferior frontal 1   Right inferior frontal 2                                                           
  -------------------------- ------------------------- ------------------------- -------------------------- -------------------------- ---- ------------ ------- ---- ----------- ------- ---- ------
  Controls                   106                       36                        **8.53606E−05**            105                        35   **0.0002**   73      33   **0.008**   62      31   0.05
  Patients                   65                        32                        **0.008**                  61                         28   0.026        52      31   0.120       46      28   0.15
  *p*-Value between groups   **0.0056**                                                                     **0.0094**                                   0.204                    0.322        

*Significant *p*-values (Bonferroni corrected, *p* \< 0.01) are highlighted*.

![Region-of-interest (ROI)-wise activation volumes---older controls show statistically significant difference before and after calibration in all regions except the right IFG2 (*p* \< 0.01, Bonferroni corrected). Patients show statistically significant difference before and after calibration in the left IFG1 (*p* \< 0.01, Bonferroni corrected). Significant group difference in the left IFG regions before (*p* \< 0.01, Bonferroni corrected) but not after calibration.](fneur-08-00283-g004){#F4}

Blood oxygenation level-dependent amplitude increased post-calibration in controls but not in patients. Between-group differences were, however, significant only prior to calibration in two of four regions; there were no significant differences after calibration in any of the ROIs. Within-group differences from pre- to post-calibration were significant for three of four regions, only in controls (Table [6](#T6){ref-type="table"} and Figure [5](#F5){ref-type="fig"}).

###### 

Region-of-interest-wise percent signal change and *p*-values (Bonferroni corrected) associated with within- and between-group differences.

                             Left inferior frontal 1   Left inferior frontal 2   Right inferior frontal 1   Right inferior frontal 2                                                               
  -------------------------- ------------------------- ------------------------- -------------------------- -------------------------- ------- ------- ------- ------- ----------- ------- ------- ------------
  Controls                   0.53                      1.04                      **8.53606E−05**            0.93                       1.03    0.357   0.72    1.02    **0.007**   0.64    1.03    **0.0008**
  Patients                   1.01                      1.00                      0.98                       1.63                       0.96    0.021   1.21    0.99    0.385       1.22    1.00    0.489
  *p*-Value between groups   **0.002**                 0.687                                                **0.006**                  0.494           0.034   0.755               0.037   0.820   

*Significant *p*-values (Bonferroni corrected, *p* \< 0.01) are highlighted*.

![Region-of-interest (ROI)-wise blood oxygenation level-dependent amplitude defined as conventional percent signal change for uncalibrated data and tSD (task) ÷ tSD (rest) (temporal SD of task divided by temporal SD of rest) for calibrated data: older controls show statistically significant difference before and after calibration in all regions except the left IFG2 (*p* \< 0.01, Bonferroni corrected). Patients show trend toward significant difference before and after calibration in the left IFG2 (*p* = 0.02). Significant (*p* \< 0.01, Bonferroni corrected) group difference in the left IFG regions before but not after calibration.](fneur-08-00283-g005){#F5}

Brain--Behavior Correlations {#S3-4}
----------------------------

Exploratory Pearson correlations between ROI-wise brain measures and verbal fluency normed scores showed trend toward significance only in patients. For activation volume, prior to calibration, Pearson *r* = −0.56, *p* = 0.029 (in the right IFG1), this did not survive significance after calibration. For amplitude, prior to calibration, Pearson *r* = −0.54, *p* = 0.037 (in the right IFG1) and *r* = −0.56, *p* = 0.028 (in the right IFG2) but these did not survive significance after calibration. Note with four ROIs, a *p* \< 0.01 would be considered statistically significant here, so *p* \< 0.05 here is considered only a trend.

Discussion {#S4}
==========

Task fMRI has been extensively used to map between-subject variability in healthy controls and to track post-stroke recovery ([@B23], [@B25]--[@B27]). However, several studies have indicated that neurovascular coupling may be compromised with aging in healthy subjects and in patient populations ([@B4], [@B5], [@B8], [@B11]). A common assumption routinely made in task fMRI studies is that the amplitude and delay in the hemodynamic response is quite predictable. However, studies have indicated that conventional BOLD analysis techniques may not be sensitive enough for detecting task-associated activity in stroke patients who may be susceptible to changes in neurovascular coupling following both local ischemic changes and diaschisis effects ([@B28]). There is a growing effort in the neuroimaging community to understand the effects of stroke on neurovascular coupling, and the possible implications for fMRI studies tracking stroke recovery. Our results, discussed below, however, suggest that application of the RSFA as a hemodynamic calibration factor in patient population needs more investigation before it can be routinely adopted as a hemodynamic scaling factor.

The main objective of this work was to investigate the use of a calibration parameter in the analysis of the effects of stroke on task fMRI BOLD activation. We compared results from stroke patients with a group of age-matched healthy controls before and after calibration. The calibration measure we investigated, "resting-state fluctuation amplitude (RSFA)," derived from a 10-min resting fMRI scan, may be a useful proxy for cerebrovascular reactivity, especially in patient populations, where the patient's ability to perform a breath-hold task could confound results.

Based on task fMRI studies of language recovery following stroke, it has been proposed that in the early stages there is little activation in the left hemisphere followed by a more bi-hemispheric activation in the sub-acute stage and subsequent restoration of activation in the left hemisphere in the chronic stages of stroke ([@B27]). However, what is not known is how much of the reduced activation in the left hemisphere in patients in the early stages is a result of a dysfunctional neurovascular system. Dynamic changes following stroke including structural, vascular, and perfusion changes all contribute to changes in brain activity as measured by BOLD fMRI making it challenging to directly interpret results from this technique in this patient population.

In the current study, there were significant group differences in behavioral performance on the verbal fluency task that is consistent with prior studies ([@B23]). Although none of our patients had overt clinical deficits, patients performed poorly on the fluency task. Note, by overt clinical deficits, we mean deficits that would be noted during the clinical team's evaluation as part of the patient's standard of care. A review of the patient's medical records showed that none of the patients included in this study had any documented clinical language deficits. The verbal fluency task is a neuropsychological test that is reported in this study was administered for research purposes and was not done as part of the clinical evaluation. Task fMRI results showed that prior to calibration, controls showed greater whole brain activation compared to stroke patients in the regions of the left inferior frontal gyrus, left occipital gyrus, the right inferior temporal, and cerebellar regions. However, after calibration with RSFA, there were no significant between-group differences. Quantitative comparisons were consistent with this finding with no between-group differences in activation volumes after calibration. For our ROI-wise comparison, we chose standard ROIs typically associated with activation on the verbal fluency task. Notably, both controls and patients showed differences from pre- to post-calibration in activation volumes and BOLD amplitude; however, this effect appears more pronounced in the controls than patients. Within-group changes in activation volume from pre- to post-calibration were greater for the controls (three of four regions) than for stroke patients (one of four regions). This result is consistent with a recent study from our lab ([@B11]) in which we used the breath-hold task and observed that the older controls demonstrated significantly impaired CVR compared to younger healthy controls, while stroke patients did not. Within-group changes in amplitude from pre- to post-calibration were greater for the controls (3 of 4 regions) than for stroke patients (0 of 4 regions). Taken together, these findings may suggest that CVR is upregulated in stroke patients in the early stages of stroke.

Similar to the whole brain results, ROI-wise comparisons also showed that significant between-group differences in activation volumes or the BOLD amplitude in the left inferior frontal regions disappeared after calibration. Interestingly, although activation volumes continued to be slightly greater in controls than patients, ROI-wise amplitudes after calibration appeared to be similar in patients and controls. These mixed results therefore indicate that further investigation into these differences with other hemodynamic calibration techniques is warranted ([@B29]).

Methodological Considerations {#S4-1}
-----------------------------

A basic assumption in fMRI studies investigating group differences is that the two groups have comparable neurovascular coupling. However, in the face of pathology that affect this coupling in one group (e.g., stroke) but not the other (or perhaps a different pathology in the other, e.g., aging) make these comparisons extremely difficult. So when calibration mitigates group differences, as reported in this study, it is difficult to determine if a previously existing difference (in the uncalibrated state) is now obscured by calibration, or calibration merely identified additional regions of activation for both groups, thereby reducing group differences in activation. There may be other factors that may capture the clinical deficit such as functional and structural network connectivity differences between the group, if activation differences do not capture it.

Not only alterations in the cerebral vasculature but also alterations in the complex neurochemical transformation of neural activity to changes in blood flow could also affect the measured BOLD response ([@B30]). Healthy "normal" aging is associated with changes in resting CBF and cerebral blood oxygen consumption, even in the absence of gross pathology. In order to address these aspects, we will need to evaluate different calibration methods in a large homogenous sample of subjects as well as take into account secondary factors such as comorbidities, medications, and silent white matter lesions. However, this is beyond the scope of the current study. The current study is simply a demonstration of the application of the RSFA calibration technique in a "fairly" homogenous sample of stroke patients with patients all having left hemisphere strokes. There appears to be a difference in the analysis results when we have applied calibration vs. when no calibration was applied, and therefore there is a contribution of "a resting state fluctuation amplitude calibration method" to the analysis. How useful this method is in identifying true group differences require further studies with carefully controlled and large sample sizes.

Our study has several limitations, including relatively small sample size and studying both cortical and subcortical stroke patients. Additionally, our study differs from previous analyses using RSFA in that we have taken extra steps to reduce motion artifact, which may have confounded previous reports. Nonetheless, we found mixed results when scaling with RSFA. RSFA itself as a calibration factor is relatively novel but is known to be sensitive to neural activity and head motion in addition to physiological changes such as variations in breathing ([@B31]); thus, correspondence with other CVR estimates should continue to be studied, particularly when proper motion correction is applied. The strengths of our study are that, we had a fairly homogenous group of stroke patients, with all left hemisphere lesions, and subjects in the two groups were matched on gender, age, and handedness.

Conclusion {#S5}
==========

Because resting fMRI can be easily acquired during a MR scan session, we recommend that hemodynamic calibration of BOLD fMRI activation in stroke patients with the RSFA should be further explored and the nature of the RSFA should be further explored as well since it may potentially be a convenient calibration factor. Although studies with larger sample sizes are needed to evaluate the effect of such calibration on brain--behavior relationships, our current study provides a first step in the application of hemodynamic calibration using the RSFA technique.
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